Thornburg Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.29M | Sell |
78,010
-7,417
| -9% | -$408K | 0.06% | 135 |
|
|
2025
Q1 | $60.4M | Sell |
85,427
-11,454
| -12% | -$8.1M | 0.08% | 118 |
|
|
2024
Q4 | $6.37M | Sell |
96,881
-26
| -0% | -$1.71K | 0.08% | 128 |
|
|
2024
Q3 | $6.81M | Sell |
96,907
-64,539
| -40% | -$4.54M | 0.09% | 133 |
|
|
2024
Q2 | $13.3M | Sell |
161,446
-3,546
| -2% | -$292K | 0.19% | 81 |
|
|
2024
Q1 | $14.4M | Sell |
164,992
-5,810
| -3% | -$507K | 0.2% | 83 |
|
|
2023
Q4 | $16.5M | Sell |
170,802
-105,276
| -38% | -$10.2M | 0.24% | 69 |
|
|
2023
Q3 | $24.4M | Buy |
276,078
+18,775
| +7% | +$1.66M | 0.4% | 53 |
|
|
2023
Q2 | $22.3M | Buy |
257,303
+105,528
| +70% | +$9.15M | 0.36% | 56 |
|
|
2023
Q1 | $14.8M | Buy |
+151,775
| New | +$14.8M | 0.24% | 75 |
|